TRCT
STIM icon

Tower Research Capital (TRC)’s Neuronetics STIM Stock Holding History

Tower Research Capital (TRC)’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Buy
19,602
+6,109
+45% +$8.89K ﹤0.01% 3334
2026
Q1 		$19.6K Buy
13,493
+5,426
+67% +$8.6K ﹤0.01% 3494
2025
Q4 		$11.1K Buy
8,067
+3,279
+68% +$6.86K ﹤0.01% 3645
2025
Q3 		$13.1K Sell
4,788
-485
-9% -$1.72K ﹤0.01% 3721
2025
Q2 		$18.4K Buy
5,273
+1,644
+45% +$6.49K ﹤0.01% 3732
2025
Q1 		$13.4K Buy
3,629
+3,386
+1,393% +$12.4K ﹤0.01% 3373
2024
Q4 		$391 Sell
243
-11,778
-98% -$12.2K ﹤0.01% 5291
2024
Q3 		$9.14K Buy
12,021
+9,497
+376% +$12.5K ﹤0.01% 3900
2024
Q2 		$4.54K Buy
+2,524
New +$7.28K ﹤0.01% 4771
2024
Q1 		– Sell
-200
Closed -$580 – 6130
2023
Q4 		$580 Sell
200
-1,667
-89% -$2.63K ﹤0.01% 5535
2023
Q3 		$2.52K Sell
1,867
-5,197
-74% -$9.11K ﹤0.01% 5139
2023
Q2 		$15.2K Sell
7,064
-5,767
-45% -$14K ﹤0.01% 3642
2023
Q1 		$37K Buy
12,831
+10,936
+577% +$55.1K ﹤0.01% 2793
2022
Q4 		$13K Sell
1,895
-340
-15% -$1.6K ﹤0.01% 3640
2022
Q3 		$7K Sell
2,235
-1,644
-42% -$5.97K ﹤0.01% 4929
2022
Q2 		$12K Sell
3,879
-20,955
-84% -$60.8K ﹤0.01% 4310
2022
Q1 		$75K Buy
24,834
+6,446
+35% +$21.8K ﹤0.01% 2412
2021
Q4 		$82K Sell
18,388
-12,046
-40% -$59K ﹤0.01% 2370
2021
Q3 		$199K Buy
30,434
+29,408
+2,866% +$282K 0.01% 1829
2021
Q2 		$16K Buy
1,026
+914
+816% +$12.6K ﹤0.01% 4091
2021
Q1 		$1K Buy
+112
New +$1.72K ﹤0.01% 5216
2020
Q3 		– Sell
-3,524
Closed -$7K – 5080
2020
Q2 		$7K Buy
3,524
+1,135
+48% +$2.33K ﹤0.01% 4167
2020
Q1 		$5K Buy
2,389
+1,215
+103% +$3.8K ﹤0.01% 2310
2019
Q4 		$5K Sell
1,174
-5,726
-83% -$35.6K ﹤0.01% 2712
2019
Q3 		$57K Buy
+6,900
New +$75.4K ﹤0.01% 1701
2019
Q1 		– Sell
-687
Closed -$13K – 4254
2018
Q4 		$13K Sell
687
-299
-30% -$6.56K ﹤0.01% 2274
2018
Q3 		$32K Buy
+986
New +$30K ﹤0.01% 2037

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tower Research Capital (TRC)'s STIM Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Neuronetics (STIM) stake by 45% in Q2 2026, buying an estimated $8.89K and bringing the position to 19,602 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3334.

Tower Research Capital (TRC) first reported a position in STIM in Q3 2018 and has held it in 27 quarters since. The position peaked at $199K in Q3 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Tower Research Capital (TRC) held 19,602 shares of Neuronetics worth $25.5K as of Q2 2026.
  • Tower Research Capital (TRC) bought 6,109 Neuronetics shares in Q2 2026, an estimated $8.89K.
  • Neuronetics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3334 holding.
  • Tower Research Capital (TRC) first reported a position in Neuronetics in Q3 2018 and has held it in 27 quarters since.
  • Tower Research Capital (TRC)'s Neuronetics position peaked at $199K in Q3 2021.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.